Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
INR 154.9
(1.6%)
INR 154.9
(1.6%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 477.02 Million INR | 1.9% |
| 2022 | 457.33 Million INR | 32.29% |
| 2021 | 345.69 Million INR | -46.27% |
| 2020 | 643.36 Million INR | 20.56% |
| 2019 | 533.65 Million INR | 27.08% |
| 2018 | 419.91 Million INR | 1.19% |
| 2017 | 414.99 Million INR | 147.7% |
| 2016 | 167.53 Million INR | -21.91% |
| 2015 | 214.54 Million INR | -29.65% |
| 2014 | 304.98 Million INR | 19.54% |
| 2013 | 255.12 Million INR | 107.49% |
| 2012 | 122.96 Million INR | 35.49% |
| 2011 | 90.75 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 357.1 Million INR | 1111.85% |
| 2024 Q2 | 39.88 Million INR | -88.83% |
| 2023 Q1 | 360.48 Million INR | 974.88% |
| 2023 FY | 466 Million INR | 1.9% |
| 2023 Q3 | 49.22 Million INR | 2.23% |
| 2023 Q2 | 48.15 Million INR | -86.64% |
| 2023 Q4 | 29.46 Million INR | -40.14% |
| 2022 Q4 | 33.53 Million INR | -32.92% |
| 2022 Q2 | 42.79 Million INR | -87.33% |
| 2022 FY | 457.33 Million INR | 32.29% |
| 2022 Q1 | 337.66 Million INR | 254.27% |
| 2022 Q3 | 49.99 Million INR | 16.82% |
| 2021 Q1 | 478.53 Million INR | 424.66% |
| 2021 Q4 | -218.87 Million INR | -510.66% |
| 2021 FY | 345.69 Million INR | -46.27% |
| 2021 Q3 | 53.29 Million INR | 42.47% |
| 2021 Q2 | 37.41 Million INR | -92.18% |
| 2020 FY | 643.36 Million INR | 20.56% |
| 2020 Q4 | 91.2 Million INR | 37.38% |
| 2020 Q1 | 435.27 Million INR | 719.32% |
| 2020 Q2 | 51.78 Million INR | -88.1% |
| 2020 Q3 | 66.39 Million INR | 28.2% |
| 2019 Q4 | 53.12 Million INR | -6.78% |
| 2019 Q3 | 56.98 Million INR | 14.71% |
| 2019 FY | 533.65 Million INR | 27.08% |
| 2019 Q1 | 371.95 Million INR | 1160.31% |
| 2019 Q2 | 49.67 Million INR | -86.64% |
| 2018 Q3 | 60.09 Million INR | 25.4% |
| 2018 Q4 | 29.51 Million INR | -50.89% |
| 2018 FY | 419.91 Million INR | 1.19% |
| 2018 Q1 | 276.3 Million INR | 705.73% |
| 2018 Q2 | 47.92 Million INR | -82.65% |
| 2017 Q4 | 34.29 Million INR | -13.09% |
| 2017 FY | 414.99 Million INR | 147.7% |
| 2017 Q1 | 231.17 Million INR | 6129.45% |
| 2017 Q2 | 36.02 Million INR | -84.42% |
| 2017 Q3 | 39.45 Million INR | 9.52% |
| 2016 Q1 | 187.18 Million INR | 797.29% |
| 2016 Q3 | 43.3 Million INR | 80.39% |
| 2016 Q4 | 3.71 Million INR | -91.43% |
| 2016 Q2 | 24 Million INR | -87.17% |
| 2016 FY | 167.53 Million INR | -21.91% |
| 2015 Q3 | 7.78 Million INR | 111.37% |
| 2015 Q4 | -26.84 Million INR | -444.73% |
| 2015 Q2 | -68.47 Million INR | -128.48% |
| 2015 Q1 | 240.44 Million INR | 579.96% |
| 2015 FY | 214.54 Million INR | -29.65% |
| 2014 FY | 304.98 Million INR | 19.54% |
| 2014 Q4 | -50.09 Million INR | -971.7% |
| 2014 Q3 | 5.74 Million INR | -43.17% |
| 2014 Q2 | 10.11 Million INR | -96.86% |
| 2014 Q1 | 322.31 Million INR | 1212.52% |
| 2013 Q4 | -28.97 Million INR | -185.0% |
| 2013 FY | 255.12 Million INR | 107.49% |
| 2013 Q1 | 229.05 Million INR | 1792.24% |
| 2013 Q2 | 20.96 Million INR | -90.85% |
| 2013 Q3 | 34.08 Million INR | 62.6% |
| 2012 Q1 | 266.86 Million INR | 0.0% |
| 2012 Q3 | 28.34 Million INR | 151.31% |
| 2012 Q4 | -13.53 Million INR | -147.75% |
| 2012 Q2 | 11.28 Million INR | -95.77% |
| 2012 FY | 122.96 Million INR | 35.49% |
| 2011 FY | 90.75 Million INR | 0.0% |